LexDanaLexDanabeta
Inventor

Timothy A. Riley

Inventor
Worcester, MA, US

Overview

46→
Patents
1998–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds14%
C07HSugars10%
C12NMicroorganisms or enzymes6%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
C08LCompositions of macromolecular compounds2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,844,076Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine202010,806,794Protease inhibitors having enhanced features202010,525,054Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound202010,512,644Oligomer-opioid agonist conjugates201910,307,416Oligomer-opioid agonist conjugates201910,231,984Oligomer-foscarnet conjugates201910,189,859Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine201910,143,690Oligomer-opioid agonist conjugates201810,098,865Multi-arm polymeric prodrug conjugates of taxane-based compounds201810,092,656Protease inhibitors having enhanced features20189,925,182'Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound'20189,827,239Oligomer-opioid agonist conjugates20179,670,235'Oligomer-foscarnet conjugates'20179,512,135'Oligomer-opioid agonist conjugates'20169,470,698'Systems and methods for non-fasting LDL cholesterol assays'20169,458,166'Oligomer-opioid agonist conjugates'20169,457,024'Compositions, dosage forms, and co-administration of an opioid agonist compound and a non-steroidal anti-inflammatory drug'20169,433,684'Conjugates of small-interfering nucleic acids'20169,365,604'Oligomer-nucleoside phosphate conjugates'20169,233,167'Oligomer-opioid agonist conjugates'20169,233,168'Oligomer-opioid agonist conjugates'20169,207,184'Systems and methods for non-fasting LDL cholesterol assays'20159,149,538'Oligomer conjugates of heteropentacyclic nucleosides'20159,089,610'Complexes of small-interfering nucleic acids'20159,006,219'Oligomer-foscarnet conjugates'20158,952,032'Oligomer-opioid agonist conjugates'20158,946,285'Oligomer-opioid agonist conjugates'20158,778,898'Oligomer conjugates of heteropentacyclic nucleosides'20148,741,858'Oligomer-nucleoside phosphate conjugates'20148,575,196'Oligomer-opioid agonist conjugates'20138,569,343'Oligomer-opioid agonist conjugates'20138,466,276'Oligomer conjugates of heteropentacyclic nucleosides'20138,440,687'Oligomer-opioid agonist conjugates'20138,173,666'Oligomer-opioid agonist conjugates'20128,153,772'Oligonucleotide probes and primers comprising universal bases for diagnostic purposes'20127,994,143'Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates'20117,790,877'Antisense oligonucleotides with increased RNase sensitivity'20107,749,983'Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates'20106,518,017'Combinatorial antisense library'20036,028,188'Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages'20005,955,597'Chirally enriched synthetic phosphate oligomers'19995,837,856'Chirally enriched synthetic phosphonate oligomers'19985,811,538'Process for the purification of oligomers'19985,792,615'Synthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages'19985,726,300'Process for the synthesis of oligonucleotides and analogs with low water oxidation step'19985,723,599'Organic polymer reagents for solid phase synthesis of oligonucleotides'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2000Patents assigned to GENTA INC (7)· patent assignee history
1998–2000Based in Nipomo, CA, US· patent location history
2003–2012Based in San Diego, CA, US· patent location history
2011–2016Based in Huntsville, AL, US· patent location history
2012–2020Patents assigned to NEKTAR THERAPEUTICS (31)· patent assignee history
2012–2016Patents assigned to RILEY TIMOTHY A (10)· patent assignee history
2012–2014Patents assigned to RIGGS-SAUTHIER JENNIFER (6)· patent assignee history
2012–2013Patents assigned to DENG BO-LIANG (5)· patent assignee history
2013–2017Based in Alameda, CA, US· patent location history
2016–2020Based in Worcester, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NEKTAR THERAPEUTICS312012–2020
RILEY TIMOTHY Aself102012–2016
GENTA INC71998–2000
RIGGS-SAUTHIER JENNIFER62012–2014
DENG BO-LIANG52012–2013
Locations
LocationPatentsSpan
Worcester, Massachusetts, US142016–2020
Alameda, California, US102013–2017
Huntsville, AL, US82011–2016
Nipomo, California, US51998–2000
San Diego, California, US32003–2012